Joint and Muscle Assessments of the Separate Effects of Botulinum NeuroToxin-A and Lower-Leg Casting in Children With Cerebral Palsy

被引:11
作者
Peeters, Nicky [1 ,2 ]
Van Campenhout, Anja [3 ]
Hanssen, Britta [1 ,2 ]
Cenni, Francesco [2 ]
Schless, Simon-Henri [4 ]
Van den Broeck, Christine [2 ]
Desloovere, Kaat [1 ,5 ]
Bar-On, Lynn [1 ,6 ]
机构
[1] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium
[2] Univ Ghent, Dept Rehabil Sci, Ghent, Belgium
[3] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium
[4] Alyn Hosp, Mot Anal & Biofeedback Lab, Jerusalem, Israel
[5] UZ Leuven, Clin Mot Anal Lab, Pellenberg, Belgium
[6] Amsterdam UMC, Amsterdam Movement Sci, Dept Rehabil Med, Amsterdam, Netherlands
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
关键词
cerebral palsy; tendon length; muscle length; spasticity; hyper-resistance; casting; Botulinum NeuroToxin; muscle stretch reflex; TOXIN-A; GASTROCNEMIUS-MUSCLE; RELIABILITY; SPASTICITY; INJECTION; TENDON; ANKLE; VALIDITY; STRETCH; GROWTH;
D O I
10.3389/fneur.2020.00210
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Botulinum NeuroToxin-A (BoNT-A) injections to the medial gastrocnemius (MG) and lower-leg casts are commonly combined to treat ankle equinus in children with spastic cerebral palsy (CP). However, the decomposed treatment effects on muscle or tendon structure, stretch reflexes, and joint are unknown. In this study, BoNT-A injections to the MG and casting of the lower legs were applied separately to gain insight into the working mechanisms of the isolated treatments on joint, muscle, and tendon levels. Thirty-one children with spastic CP (GMFCS I-III, age 7.4 +/- 2.6 years) received either two weeks of lower-leg casts or MG BoNT-A injections. During full range of motion slow and fast passive ankle rotations, joint resistance and MG stretch reflexes were measured. MG muscle and tendon lengths were assessed at resting and at maximum dorsiflexion ankle angles using 3D-freehand ultrasound. Treatment effects were compared using non-parametric statistics. Associations between the effects on joint and muscle or tendon levels were performed using Spearman correlation coefficients (p < 0.05). Increased joint resistance, measured during slow ankle rotations, was not significantly reduced after either treatment. Additional joint resistance assessed during fast rotations only reduced in the BoNT-A group (-37.6%, p = 0.013, effect size = 0.47), accompanied by a reduction in MG stretch reflexes (-70.7%, p = 0.003, effect size = 0.56). BoNT-A increased the muscle length measured at the resting ankle angle (6.9%, p = 0.013, effect size = 0.53). Joint angles shifted toward greater dorsiflexion after casting (32.4%, p = 0.004, effect size = 0.56), accompanied by increases in tendon length (5.7%, p = 0.039, effect size = 0.57; r = 0.40). No associations between the changes in muscle or tendon lengths and the changes in the stretch reflexes were found. We conclude that intramuscular BoNT-A injections reduced stretch reflexes in the MG accompanied by an increase in resting muscle belly length, whereas casting resulted in increased dorsiflexion without any changes to the muscle length. This supports the need for further investigation on the effect of the combined treatments and the development of treatments that more effectively lengthen the muscle.
引用
收藏
页数:11
相关论文
共 45 条
  • [1] Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study
    Alexander, Caroline
    Elliott, Catherine
    Valentine, Jane
    Stannage, Katherine
    Bear, Natasha
    Donnelly, Cyril J.
    Shipman, Peter
    Reid, Siobhan
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2018, 60 (11) : 1165 - 1171
  • [2] Altman D.G., 1990, Practical Statistics for Medical Research, V1st ed.
  • [3] [Anonymous], 2016, NAT REV DIS PRIMERS, DOI DOI 10.1038/nrdp.2015.82
  • [4] Presynaptic inhibition and homosynaptic depression -: A comparison between lower and upper limbs in normal human subjects and patients with hemiplegia
    Aymard, C
    Katz, R
    Lafitte, C
    Lo, E
    Pénicaud, A
    Pradat-Diehl, P
    Raoul, S
    [J]. BRAIN, 2000, 123 : 1688 - 1702
  • [5] Instrumented assessment of the effect of Botulinum Toxin-A in the medial hamstrings in children with cerebral palsy
    Bar-On, L.
    Aertbelien, E.
    Molenaers, G.
    Van Campenhout, A.
    Vandendoorent, B.
    Nieuwenhuys, A.
    Jaspers, E.
    Hunaerts, C.
    Desloovere, K.
    [J]. GAIT & POSTURE, 2014, 39 (01) : 17 - 22
  • [6] A clinical measurement to quantify spasticity in children with cerebral palsy by integration of multidimensional signals
    Bar-On, L.
    Aertbelien, E.
    Wambacq, H.
    Severijns, D.
    Lambrecht, K.
    Dan, B.
    Huenaerts, C.
    Bruyninckx, H.
    Janssens, L.
    Van Gestel, L.
    Jaspers, E.
    Molenaers, G.
    Desloovere, K.
    [J]. GAIT & POSTURE, 2013, 38 (01) : 141 - 147
  • [7] The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study
    Barber, Lee
    Hastings-Ison, Tandy
    Baker, Richard
    Graham, H. Kerr
    Barrett, Rod
    Lichtwark, Glen
    [J]. JOURNAL OF CHILDRENS ORTHOPAEDICS, 2013, 7 (05) : 425 - 433
  • [8] INTERRATER RELIABILITY OF A MODIFIED ASHWORTH SCALE OF MUSCLE SPASTICITY
    BOHANNON, RW
    SMITH, MB
    [J]. PHYSICAL THERAPY, 1987, 67 (02): : 206 - 207
  • [9] Changes in spastic muscle stiffness after botulinum toxin A injections as part of rehabilitation therapy in patients with spastic cerebral palsy
    Boyaci, Ahmet
    Tutoglu, Ahmet
    Boyaci, Nurefsan
    Koca, Irfan
    Calik, Mustafa
    Sakalar, Ali
    Kilicaslan, Nihat
    [J]. NEUROREHABILITATION, 2014, 35 (01) : 123 - 129
  • [10] Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy
    Boyd, RN
    Graham, HK
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 : S23 - S35